Medical News

RSS

I write about America’s absurd health care system. Then I got caught up in it.

I got a hurried voicemail from my pharmacist in Wisconsin the day before Thanksgiving letting me know my insurance was refusing to cover my insulin.

25 Jan 2022

Growth advantage of SARS-CoV-2 Omicron variant found to be partly due to shorter serial interval

In a new study, a team of researchers assessed how serial intervals of SARS-CoV-2 Omicron and Delta variants varied during the same time period in the Netherlands.

25 Jan 2022

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

In a new study, a team of researchers reviewed the published literature to find evidence for humoral SARS-CoV-2 correlate of protection (CoP).

25 Jan 2022

Accelerating the COVID-19 booster vaccination rate to prevent Omicron variant hospitalizations and deaths

A new study investigates the impact of accelerating the pace of COVID-19 booster vaccination rates in the US in reducing COVID-19-related hospitalizations and mortalities.

25 Jan 2022

Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

Scientists have recently used synthetic biology to design primary human CD8 T cells to express Spike protein-specific chimeric antigen receptors (ACE2 CAR or anti-Spike CAR).

25 Jan 2022

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

A new study has focused on the identification, in vitro binding, and potent neutralizing activity of STI-9167 (plutavimab) against live viruses and pseudotype viruses.

25 Jan 2022

Impact of a third BNT162b2 dose on SARS-CoV-2 Omicron variant

In a new study, researchers assessed the extent and duration of the neutralization of SARS-CoV-2 Omicron variant of concern after the administration of two and three doses of the BNT162b2 mRNA vaccine.

25 Jan 2022

New therapeutic approach offers hope to treat obesity and related metabolic disorders

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new therapeutic approach to obesity and related metabolic disorders that in laboratory experiments demonstrated a significant reduction in body fat, body weight, and improvement in the blood markers that accompany these disorders.

25 Jan 2022

Study opens the door to a new approach to attacking herpesviruses

A new study published this week in mBio, an open access journal of the American Society for Microbiology, has opened the door to a new approach to attacking herpesviruses.

25 Jan 2022

Study reveals a widening gender gap in the field of family medicine due to COVID-19

As people transitioned to working from home at the onset of the coronavirus pandemic, journal submissions from academics increased across the board. But a new study from Northwestern University found as men's scholarly productivity increased, women physicians were submitting less.

25 Jan 2022

Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

Patients with alcohol-associated cirrhosis have poorer outcomes after ICU discharge, compared to patients with cirrhosis linked to other causes, according to new Mayo Clinic research.

25 Jan 2022

Seeing the same GP over time lowers the rates of health complications in people with dementia

People with dementia who see the same GP each time have lower rates of health complications and fewer emergency hospital admissions, according to a new study.

25 Jan 2022

New, more accurate tool to measure the progress of lupus in patients

A new paper in Rheumatology, published by Oxford University Press, indicates that researchers have developed a new, easier, and more accurate tool to measure the progress of lupus in patients.

25 Jan 2022

Lucky genes can help lower risk of diseases in people with obesity

Geneticists have revealed why some people with obesity remain relatively healthy, whilst others suffer from life-changing ailments such as type 2 diabetes and heart disease.

25 Jan 2022

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

A new preprint available on medRxiv* demonstrates the marked improvement in the immune response when the mRNA vaccine BNT162b2, from Pfizer/BioNTech, is used for the third dose after a primary two-dose series of an inactivated whole virus vaccine.

25 Jan 2022

Genetic diagnosis in cerebral palsy patients could change the approach to care

Cerebral palsy, a non-progressing motor impairment that begins in early childhood, has widely been viewed as the result of oxygen deprivation during birth or other birth-related factors such as prematurity.

25 Jan 2022

Differences found in health-related quality of life among men and women with advanced kidney disease

In a CJASN study of older men and women with advanced kidney disease, women had lower health-related quality of life at the start, but men experienced a more rapid decline over time.

25 Jan 2022

Evaluation of cross-reactive T cell responses between SARS-CoV-2 and common-cold human coronaviruses

A new study investigated SARS-CoV-2 spike protein responses targeted by cross-reactive T cells that were isolated from convalescent COVID-19 individuals along with previously uninfected donors.

25 Jan 2022

Researchers discover a potential new way to combat antibiotic resistance

Researchers from Monash University have discovered a potential new way to prevent antibiotic resistance and reduce antibiotic intake.

25 Jan 2022

La Trobe researcher aims to prevent the rise of knee arthritis in young Australians

Australians have the highest rates of ACL (anterior cruciate ligament) knee injuries worldwide, and young Australians are most at risk, with a 74% increase in knee surgery in people under 25 since 2000. Half the people who’ve had a knee reconstruction develop knee arthritis in their 30s, which means a less active lifestyle and potentially even a knee replacement in middle-age.

25 Jan 2022

Medical News

I write about America’s absurd health care system. Then I got caught up in it.

Growth advantage of SARS-CoV-2 Omicron variant found to be partly due to shorter serial interval

Humoral correlate of protection for SARS-CoV-2 may reduce COVID-19 infection risk

Accelerating the COVID-19 booster vaccination rate to prevent Omicron variant hospitalizations and deaths

Development of synthetic molecules that can bridge T cells with SARS-CoV-2 infected cells

Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

Impact of a third BNT162b2 dose on SARS-CoV-2 Omicron variant

New therapeutic approach offers hope to treat obesity and related metabolic disorders

Study opens the door to a new approach to attacking herpesviruses

Study reveals a widening gender gap in the field of family medicine due to COVID-19

Study finds poorer outcomes after ICU discharge in patients with alcohol-associated cirrhosis

Seeing the same GP over time lowers the rates of health complications in people with dementia

New, more accurate tool to measure the progress of lupus in patients

Lucky genes can help lower risk of diseases in people with obesity

Immunogenicity to BNT162b2 booster in adults who had previously received inactivated COVID-19 vaccination

Genetic diagnosis in cerebral palsy patients could change the approach to care

Differences found in health-related quality of life among men and women with advanced kidney disease

Evaluation of cross-reactive T cell responses between SARS-CoV-2 and common-cold human coronaviruses

Researchers discover a potential new way to combat antibiotic resistance

La Trobe researcher aims to prevent the rise of knee arthritis in young Australians

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News